Officer files to sell 50,000 shares after option exercise

Insider sale notice: A Form 144 reports a proposed sale of 50,000 shares of Common Stock related to an exercise of stock options, dated 05/05/2026, with cash proceeds specified.

Rhea-AI Filing Summary

Insider sale notice: A Form 144 reports a proposed sale of 50,000 shares of Common Stock related to an exercise of stock options, dated 05/05/2026, with cash proceeds specified. The filing also lists recent Rule 10b5-1 sales totaling 71,588 shares across March–May 2026.

Insights

Securities Compliance Analyst

Form 144 lists a planned 50,000-share disposition after an option exercise.

The filing documents an exercise of stock options and a proposed sale of 50,000 shares on 05/05/2026. Prior Rule 10b5-1 sales are recorded: 5,230 shares on 05/04/2026, 28,662 on 04/01/2026, 21,338 on 03/31/2026, and 16,358 on 03/27/2026.

These entries are routine regulatory disclosures that permit public resale following an option exercise. Cash‑flow treatment is shown as cash for the planned sale; exact proceeds for the 50,000 shares are listed in the excerpt.

Key Figures

Proposed sale: 50,000 shares 10b5-1 sale (May): 5,230 shares 10b5-1 sale (Apr): 28,662 shares +3 more

6 metrics

Proposed sale 50,000 shares to be sold following exercise of stock options on 05/05/2026

10b5-1 sale (May) 5,230 shares sale on 05/04/2026; proceeds <money>$163,662.91</money>

10b5-1 sale (Apr) 28,662 shares sale on 04/01/2026; proceeds <money>$926,095.02</money>

10b5-1 sale (Mar 31) 21,338 shares sale on 03/31/2026; proceeds <money>$685,308.28</money>

10b5-1 sale (Mar 27) 16,358 shares sale on 03/27/2026; proceeds <money>$506,734.85</money>

Total recent sales 71,588 shares aggregate of listed 10b5-1 sales in Mar–May 2026

Key Terms

Form 144, 10b5-1, Exercise of Stock Options

3 terms

Form 144 regulatory

"Proposed sale of 50,000 shares related to option exercise"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 regulatory

"10b5-1 Sales for JOANNE DONOVAN listed with dates and amounts"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Securities To Be Sold: Exercise of Stock Options (cash)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does EWTX's Form 144 disclose?

It discloses a proposed sale of 50,000 shares tied to an exercise of stock options on 05/05/2026. The filing also records multiple Rule 10b5-1 sales totaling 71,588 shares in March–May 2026.

Were there recent 10b5-1 sales by the reporting person?

Yes. The filing lists four 10b5-1 transactions: 16,358, 21,338, 28,662, and 5,230 shares, executed between 03/27/2026 and 05/04/2026, with aggregate proceeds shown for each trade.

What prompted the 50,000-share sale in the filing?

The filing links the planned disposition to an exercise of stock options by the reporting person on 05/05/2026. The method of sale is indicated as cash in the excerpt; further details on broker or plan terms are not provided in the excerpt.

Does the Form 144 state the cash proceeds for the 50,000 shares?

The excerpt shows cash amounts for prior 10b5-1 sales but lists a monetary figure in the header area associated with the 50,000-share line. The filing itemizes proceeds for prior trades on specific dates in March–May 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/05/2026 - 04:29 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001644087
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	EDGEWISE THERAPEUTICS INC
SEC File Number	001-40236
Address of Issuer	1715 38th Street Boulder COLORADO 80301
Phone	7202627002
Name of Person for Whose Account the Securities are To Be Sold	JOANNE DONOVAN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50000	1572500.00	107270521	05/05/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/05/2026	Exercise of Stock Options	Issuer			50000	05/05/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JOANNE DONOVAN 1715 38th Street Boulder CO 80301	Common	05/04/2026	5230	163662.91
10b5-1 Sales for JOANNE DONOVAN 1715 38th Street Boulder CO 80301	Common	04/01/2026	28662	926095.02
10b5-1 Sales for JOANNE DONOVAN 1715 38th Street Boulder CO 80301	Common	03/31/2026	21338	685308.28
10b5-1 Sales for JOANNE DONOVAN 1715 38th Street Boulder CO 80301	Common	03/27/2026	16358	506734.85

144: Remarks and Signature

Remarks
Date of Notice	05/05/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/26/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joanne Donovan
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)